The risks
pharmaceutical companies face from natural and man-made disasters are
increasing in both frequency and magnitude.
To ensure there is
minimal interruption to the production of delivery of patient treatments in the
wake of a disaster, supply chain leaders must implement a business continuity
plan.
However, many
companies are unprepared to protect their critical business functions and
products in a complex supply network.
In this report, we
shed light on the process of building a resilient supply chain, showing you how
to:
Download your copy of this report to start building resiliency in your supply chain and secure your products from disaster.
Please note: That all fields marked with an asterisk (*) are required.